Drug-induced QT interval prolongation: mechanisms and clinical management
Reads0
Chats0
TLDR
This review focuses on the mechanism of drug-induced QT prolongation, risk factors for TdP, culprit drugs, prevention and monitoring of prolonged drug- induced QT prolongedation and treatment strategies.Abstract:
The prolonged QT interval is both widely seen and associated with the potentially deadly rhythm, Torsades de Pointes (TdP). While it can occur spontaneously in the congenital form, there is a wide array of drugs that have been implicated in the prolongation of the QT interval. Some of these drugs have either been restricted or withdrawn from the market due to the increased incidence of fatal polymorphic ventricular tachycardia. The list of drugs that cause QT prolongation continues to grow, and an updated list of specific drugs that prolong the QT interval can be found at www.qtdrugs.org. This review focuses on the mechanism of drug-induced QT prolongation, risk factors for TdP, culprit drugs, prevention and monitoring of prolonged drug-induced QT prolongation and treatment strategies.read more
Citations
More filters
Journal ArticleDOI
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
Gillian C. Bell,Kelly E. Caudle,Michelle Whirl-Carrillo,Ronald J. Gordon,Keiko Hikino,Cynthia A. Prows,Andrea Gaedigk,José A. G. Agúndez,Senthilkumar Sadhasivam,Teri E. Klein,Matthias Schwab +10 more
TL;DR: Evidence from the published literature supporting associations and therapeutic recommendations for ondansetron and tropisetron based on CYP2D6 genotype are summarized and provided.
Journal ArticleDOI
Risk factors for QTc-prolongation: systematic review of the evidence
TL;DR: This systematic review gives a clear overview of the available evidence for a broad range of risk factors for QTc-prolongation.
Journal ArticleDOI
Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
TL;DR: A case of a syncopal episode resulting from significant QT interval prolongation in a patient on hydroxychloroquine for the treatment of systemic lupus erythematosus and end stage renal disease is presented.
Journal ArticleDOI
Development of Safe Drugs: The hERG Challenge.
TL;DR: The spectrum of reported binding modes for hERG blockers, the various in silico models developed for predicting a drug's affinity to hERG, and the known successful optimization strategies to avoid off‐target interactions with hERG are discussed.
Journal ArticleDOI
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
TL;DR: Hydroxychloroquine is used as a desperate attempt for prophylaxis and treatment of COVID-19, the coronavirus infection that has wide-ranging drug interactions and potential cardiotoxicity.
References
More filters
Journal ArticleDOI
Drug-induced prolongation of the QT interval.
TL;DR: The single most common cause of the withdrawal or restriction of the use of marketed drugs has been QT-interval prolongation associated with polymorphic ventricular tachycardia, or torsade de pointes, a condition that can be fatal.
Journal ArticleDOI
Genotype-Phenotype Correlation in the Long-QT Syndrome Gene-Specific Triggers for Life-Threatening Arrhythmias
Peter J. Schwartz,Silvia G. Priori,Carla Spazzolini,Arthur J. Moss,G. Michael Vincent,Carlo Napolitano,Isabelle Denjoy,Pascale Guicheney,Günter Breithardt,Mark T. Keating,Jeffrey A. Towbin,Alan H. Beggs,Paul A. Brink,Arthur A.M. Wilde,Lauri Toivonen,Wojciech Zareba,Jennifer L. Robinson,Katherine W. Timothy,Valerie A. Corfield,Duangrurdee Wattanasirichaigoon,Clive Corbett,Wilhelm Haverkamp,Eric Schulze-Bahr,Michael H. Lehmann,Ketty Schwartz,Philippe Coumel,Raffaella Bloise +26 more
TL;DR: Life-threatening arrhythmias in LQTS patients tend to occur under specific circumstances in a gene-specific manner, allowing new insights into the mechanisms that relate the electrophysiological consequences of mutations on specific genes to clinical manifestations and offer the possibility of complementing traditional therapy with gene- specific approaches.
Journal ArticleDOI
hERG potassium channels and cardiac arrhythmia
TL;DR: Insights gained from the crystal structures of other potassium channels have helped understanding of the block of hERG channels and the mechanisms of gating.
Journal ArticleDOI
Spectrum of Mutations in Long-QT Syndrome Genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
Igor Splawski,Jiaxiang Shen,Katherine W. Timothy,Michael H. Lehmann,Silvia G. Priori,Jennifer L. Robinson,Arthur J. Moss,Peter J. Schwartz,Jeffrey A. Towbin,G. Michael Vincent,Mark T. Keating +10 more
TL;DR: KVLQT1 and HERG accounted for 87% of identified mutations, and SCN5A, KCNE1, and KCNE2 accounted for the other 13%, and Missense mutations were most common, followed by frameshift mutations, in-frame deletions, and nonsense and splice-site mutations.
Journal ArticleDOI
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen Ct,Mogens Møller,P E Bloch-Thomsen,Lars Køber,Erik Sandoe,Kenneth Egstrup,Agner E,Carlsen Je,Jørgen Videbæk,Bradley Marchant,A. J. Camm +10 more
TL;DR: In patients with congestive heart failure and reduced left ventricular function, dofetilide was effective in converting atrial fibrillation, preventing its recurrence, and reducing the risk of hospitalization for worsening heart failure.